
- /
- Supported exchanges
- / US
- / ICCC.NASDAQ
ImmuCell Corporation (ICCC NASDAQ) stock market data APIs
ImmuCell Corporation Financial Data Overview
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get ImmuCell Corporation data using free add-ons & libraries
Get ImmuCell Corporation Fundamental Data
ImmuCell Corporation Fundamental data includes:
- Net Revenue: 27 303 K
- EBITDA: 2 880 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-13
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ImmuCell Corporation News

ImmuCell initiates CEO succession search ahead of planned 2026 retirement
* ImmuCell (NASDAQ:ICCC [https://seekingalpha.com/symbol/ICCC]) begins search for a new president and chief executive officer. * Current CEO Michael F. Brigham plans to retire from full-time work ...


ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
PORTLAND, Maine, June 05, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...

ImmuCell Reports Y/Y Q1 Earnings Growth on Record Sales & Margin Gains
Shares of ImmuCell Corporation ICCC have gained 3.9% since reporting results for the first quarter of 2025. This compares with the S&P 500 index’s 5.5% rise over the same time frame. Over the past m...

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025
PORTLAND, Maine, May 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.